MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s43856-025-01133-w

Медицинская библиотека · Communications medicine · 2025

Longitudinal evaluation of serum cholinesterase benefits prognosis surveillance of common types of human cancer.

Li Chunxia, Li Yanli, Liu Lizhu, You Ruimin, Fan Bingbing, Lv Jiali, You Dingyun, Li Zhenhui, Zhang Tao

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Existing literature on serum cholinesterase (ChE) in cancer prognosis have predominantly evaluated preoperative levels, ignoring serial ChE measurements during postoperative follow-up.

METHODS

5925 patients undergoing curative resection for stage I-III non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and gastric cancer (GC) were retrospectively included. Patients were divided into persistently normal, normalized, lowered and persistently low perioperative ChE patterns, as well as longitudinal ChE trajectories identified by the latent class growth mixed model (LCGMM). The associations of ChE dynamic changes with overall survival (OS) and recurrence-free survival (RFS) were evaluated.

RESULTS

Postoperative ChE emerged as an independent prognostic factor, event after accounting for preoperative levels. Perioperative ChE stratification revealed divergent survival outcomes: the persistently normal group (82.5%) demonstrated 8.6% higher 5-year OS rate than the lowered group (73.9%), while the normalized group (73.3%) had 13.9% higher 5-year OS rate than the persistently low group (59.4%). LCGMM identified three distinct longitudinal trajectories: slow-rising (5-year OS rate: 79.7%; reference group), rising-decreasing (5-year OS rate: 64.8%; adjusted HR: 1.50, 95% CI: 1.14 to 1.99) and decreasing-rising (5-year OS rate: 58.1%; adjusted HR: 2.33, 95% CI: 1.69 to 3.22). Consistent results were observed for RFS as well. Furthermore, stratified analyses confirmed statistically significant associations of ChE dynamic changes with prognosis across all histological subtypes.

CONCLUSIONS

A routine follow-up measurement of postoperative ChE was recommended to improve individualized management of cancer patients.

Для цитирования: Li Chunxia, Li Yanli, Liu Lizhu, You Ruimin, Fan Bingbing, Lv Jiali, You Dingyun, Li Zhenhui, Zhang Tao. Longitudinal evaluation of serum cholinesterase benefits prognosis surveillance of common types of human cancer.. Communications medicine. 2025. DOI: 10.1038/s43856-025-01133-w.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.